John C. Wain, MD

Assistant Professor, Department of Surgery, Harvard Medical School

Visiting Surgeon, Surgery, Massachusetts General Hospital

Contact Info

John Wain
Massachusetts General Hospital
55 Fruit Street
Boston, MA, 02114
Phone: 617-726-5200
Fax: 617-726-7667
jwain@partners.org

Assistant

Paulette Nadeau
Administrative Assistant
Surgery
Harvard Medical School
55 Fruit Street
Boston, MA, 02114
Phone: 617-726-5200
Fax: 617-726-7667
pnadeau@partners.org

DF/HCC Program Affiliation

Lung Cancer

Research Abstract

I have a background in molecular biology and clinical outcomes research. To date, I have participated in a program project grant on molecular epidemology of carcinogen metabolism that used case control studies of lung cancer patients, and epigenetic analysis of tumor samples, to confirm the role of differences in carcinogen metabolism in susceptibility to lung cancer. Currently, I am pursuing outcome analysis of resected lung cancer patients with varying anatomic sites of lymph node metastasis and further molecular epidemiologic studies of adenocarcinoma of the lung.

Publications

View All Publications

Advanced search
DF/HCC Directory Login Update Member Profile Change Account Settings Applying for Membership Benefits Requirements Responsibilities	John C. Wain, MD Assistant Professor, Department of Surgery, Harvard Medical School Visiting Surgeon, Surgery, Massachusetts General Hospital Contact Info John Wain Massachusetts General Hospital 55 Fruit Street Boston, MA, 02114 Phone: 617-726-5200 Fax: 617-726-7667 jwain@partners.org Assistant Paulette Nadeau Administrative Assistant Surgery Harvard Medical School 55 Fruit Street Boston, MA, 02114 Phone: 617-726-5200 Fax: 617-726-7667 pnadeau@partners.org DF/HCC Program Affiliation Lung Cancer Research Abstract I have a background in molecular biology and clinical outcomes research. To date, I have participated in a program project grant on molecular epidemology of carcinogen metabolism that used case control studies of lung cancer patients, and epigenetic analysis of tumor samples, to confirm the role of differences in carcinogen metabolism in susceptibility to lung cancer. Currently, I am pursuing outcome analysis of resected lung cancer patients with varying anatomic sites of lymph node metastasis and further molecular epidemiologic studies of adenocarcinoma of the lung. Publications View All Publications
Site Map Site Feedback Web Privacy Policy